Age and Gender Variations in Cancer Diagnostic Intervals in 15 Cancers: Analysis of Data from the UK Clinical Practice Research Datalink
Open Access
- 15 May 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5), e0127717
- https://doi.org/10.1371/journal.pone.0127717
Abstract
Time from symptomatic presentation to cancer diagnosis (diagnostic interval) is an important, and modifiable, part of the patient’s cancer pathway, and can be affected by various factors such as age, gender and type of presenting symptoms. The aim of this study was to quantify the relationships of diagnostic interval with these variables in 15 cancers diagnosed between 2007 and 2010 using routinely collected data from the Clinical Practice Research Datalink (CPRD) in the UK. Symptom lists for each cancer were prepared from the literature and by consensus amongst the clinician researchers, which were then categorised into either NICE qualifying (NICE) or not (non-NICE) based on NICE Urgent Referral Guidelines for Suspected Cancer criteria. Multivariable linear regression models were fitted to examine the relationship between diagnostic interval (outcome) and the predictors: age, gender and symptom type. 18,618 newly diagnosed cancer patients aged ≥40 who had a recorded symptom in the preceding year were included in the analysis. Mean diagnostic interval was greater for older patients in four disease sites (difference in days per 10 year increase in age; 95% CI): bladder (10.3; 5.5 to 15.1; Pnon-NICE symptoms in 10 of 15 cancers (mean difference in days; 95% CI): bladder (62.9; 48.7 to 77.2; Pnon-NICE symptoms (27.7 days; 23.9 to 31.5; P<0.001). We found age and gender-specific inequalities in time to diagnosis for some but not all cancer sites studied. Whilst these need further explanation, these findings can inform the development and evaluation of interventions intended to achieve timely diagnosis and improved cancer outcomes, such as to provide equity across all age and gender groupings.Keywords
This publication has 46 references indexed in Scilit:
- Gender differences in attitudes impeding colorectal cancer screeningBMC Public Health, 2013
- Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?British Journal of Cancer, 2013
- The Aarhus statement: improving design and reporting of studies on early cancer diagnosisBritish Journal of Cancer, 2012
- Features of childhood cancer in primary care: a population-based nested case–control studyBritish Journal of Cancer, 2012
- Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods studyBritish Journal of Cancer, 2011
- Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinomaBritish Journal of Cancer, 2011
- Explaining the difference in prognosis between screen-detected and symptomatic breast cancersBritish Journal of Cancer, 2011
- Time to diagnosis and mortality in colorectal cancer: a cohort study in primary careBritish Journal of Cancer, 2011
- The National Awareness and Early Diagnosis Initiative in England: assembling the evidenceBritish Journal of Cancer, 2009
- Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survivalBritish Journal of Cancer, 2009